Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Sanofi”
- Isa-Pom-Dex in Elderly/Frail Subjects With RRMMActive Not Recruiting
Sponsor: UNC Lineberger Comprehensive Cancer Center
Multiple Myeloma · Relapse · Refractory · Aging
United States
Sponsor: M.D. Anderson Cancer Center
Multiple Myeloma
United States
- SAR447971 First-in-human StudyRecruiting
Sponsor: Sanofi
Hidradenitis · Healthy Volunteers
Netherlands
Sponsor: Sanofi
Acute Myeloid Leukaemia
United States
- Efficacy, Safety and Pharmacokinetics of Rilzabrutinib in Patients With Warm Autoimmune Hemolytic Anemia (wAIHA)Active Not Recruiting
Sponsor: Sanofi
Warm Autoimmune Hemolytic Anemia (wAIHA)
United States, Austria, China, Denmark, Germany +4 more
Sponsor: Sanofi
Asthma
France
Sponsor: Sanofi
Chronic Graft Versus Host Disease
United States, Belgium, Canada, China, France +8 more
Sponsor: Sanofi
COVID-19 · SARS-CoV-2 Infection
United States
- Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in FranceActive Not Recruiting
Sponsor: Sanofi
Chronic Rhinosinusitis With Nasal Polyposis
France
Sponsor: Regeneron Pharmaceuticals
Asthma
United States, Canada, Denmark, France, Italy +5 more
- A Prospective Assessment of Bone Health in Patients With Severe Hemophilia A on Factor VIII vs Factor Mimetic Prophylaxis (Efa Emi Bone Health Study)Not Yet Recruiting
Sponsor: Arkansas Children's Hospital Research Institute
Hemophilia a
Sponsor: Dana-Farber Cancer Institute
Multiple Myeloma
United States
- COPD Exacerbation Follow UpRecruiting
Sponsor: Viz.ai, Inc.
COPD (Chronic Obstructive Pulmonary Disease)
United States
- KRDI in Transplant-Eligible MMActive Not Recruiting
Sponsor: Massachusetts General Hospital
Multiple Myeloma
United States
Sponsor: Sanofi Pasteur, a Sanofi Company
COVID-19
United States, Colombia, Ghana, Honduras, India +6 more
Sponsor: UNC Lineberger Comprehensive Cancer Center
Multiple Myeloma · Cancer
United States
Sponsor: Sanofi
Hemophilia A
United States, Taiwan
- A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal PolypsActive Not Recruiting
Sponsor: Sanofi
Chronic Rhinosinusitis With Nasal Polyps
United States, Argentina, Australia, Belgium, Brazil +18 more
Sponsor: Sanofi
Myotonic Dystrophy
United States, Argentina, Australia, Canada, Israel +1 more
- Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and AsiaActive Not Recruiting
Sponsor: Sanofi Pasteur, a Sanofi Company
Yellow Fever
Finland, France, Germany, Singapore, Spain +1 more
- Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)Active Not Recruiting
Sponsor: Regeneron Pharmaceuticals
Atopic Dermatitis
United States, Canada, Czechia, Germany, Hungary +2 more
Sponsor: Genzyme, a Sanofi Company
Multiple Sclerosis
United States, Australia, Austria, Belgium, Canada +7 more
Sponsor: Sanofi
Relapsed/Refractory Multiple Myeloma · Amyloid Light-chain Amyloidosis
Australia, Belgium, Czechia, Hungary, Italy +2 more
Sponsor: Sanofi
Type 1 Diabetes
United States, Israel, United Arab Emirates
Sponsor: Sanofi
Type 1 Diabetes
Belgium, France, Italy, Spain, United Kingdom